Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

50.32
-0.5050-0.99%
Volume:1.31M
Turnover:65.93M
Market Cap:101.77B
PE:16.09
High:50.81
Open:50.50
Low:50.31
Close:50.82
52wk High:61.70
52wk Low:38.63
Shares:2.02B
Float Shares:2.00B
Volume Ratio:0.56
T/O Rate:0.07%
Dividend:1.84
Dividend Rate:3.66%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.26
PE(LYR):13.47

Loading ...

J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 29

GlaxoSmithKline (GSK) Gets a Sell from Barclays

TIPRANKS
·
Jun 29

GSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors

TIPRANKS
·
Jun 27

Dodge & Cox lifts GSK stake above 5% as institutional backing grows

TIPRANKS
·
Jun 26

GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing

TIPRANKS
·
Jun 26

GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential

TIPRANKS
·
Jun 26

GSK Rallies Thursday, Outperforms Market

Dow Jones
·
Jun 26

GSK to Deliver Earnings Growth over Next Decade

Dow Jones
·
Jun 25

Gsk's HIV Franchise Seems Underappreciated

Dow Jones
·
Jun 25

Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 25

GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch

TIPRANKS
·
Jun 25

GSK Unit Launches Tender Offer for Nuvalent Acquisition

MT Newswires Live
·
Jun 25

GSK Discloses Executive Notional ADS Acquisition by U.S. President

TIPRANKS
·
Jun 24

GSK launches $124-per-share tender offer to acquire oncology developer Nuvalent

TIPRANKS
·
Jun 24

GSK Climbs Tuesday, Outperforms Market

Dow Jones
·
Jun 24

GSK board members boost holdings with coordinated share purchases

TIPRANKS
·
Jun 23

GSK's Nuvalent Deal Could Be Rare Case of Profitable Oncology Acquisition -- Market Talk

Dow Jones
·
Jun 23

GSK Expands Treasury Stock Position with June Share Buybacks

TIPRANKS
·
Jun 22

GSK Targets Relapsed B-Cell Lymphoma With New Early-Stage Trial

TIPRANKS
·
Jun 19

GSK’s ZEAL-1L Lung Cancer Trial Delivers Mixed Readout With Limited Upside for Niraparib

TIPRANKS
·
Jun 19